What is the address of DEXAMED?

The registered office of DEXAMED is located at Blauwhuisstraat 26, 8020 Oostkamp.

Is DEXAMED still active?

Yes. According to the CBE (29 October 2026) DEXAMED is active, legal situation “Normale toestand”, started on 8 January 2007.

Is DEXAMED registered on Peppol?

Yes, DEXAMED is registered on the Peppol network with ID 0208:0886182892.

What is the enterprise number of DEXAMED?

The enterprise number of DEXAMED is BE0886182892.

When was DEXAMED founded?

DEXAMED was founded on 8 January 2007.

Who are the directors of DEXAMED?

According to the 2025 annual accounts, the directors of DEXAMED are: Xavier Deklerck.

Is DEXAMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 January 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEXAMED make in 2025?

DEXAMED posted a profit after taxes of € 11,008 in financial year 2025.

What is the revenue of DEXAMED?

As a small company, DEXAMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,983.

DEXAMED (Private Limited) - Oostkamp - BE0886182892

Q: What does DEXAMED do?

DEXAMED is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 8 January 2007, 1 establishment.

Dossier DEXAMED, printed on 29 October 2026 from databakkes.be/en/0886182892/dexamed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DEXAMED from Oostkamp, company number BE0886182892, closed financial year 2025 with a result of € 11,008 after tax. For that financial year DEXAMED recorded a gross margin of € 20,983 and equity of € 426,358. Compared with financial year 2024, the result moved from € -4,050 to € 11,008. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.

What it is worth Healthy

€ 426,358

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 11,008

▲ still € 4,050 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,074

▲ 190% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 15,720 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 30,806

▲ 53% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 50,155

▼ 20% vs 2024

€ 13,331 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 6,910

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,243

▲ 15% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,394 Gross margin 2022: € 70,394 First fiscal year in the series	€ -10,613 Gross margin 2023: € -10,613 ▼ € 81,007 vs 2022 (€ 70,394) Unfavourable step	€ 8,634 Gross margin 2024: € 8,634 ▲ € 19,248 vs 2023 (€ -10,613) Favourable step	€ 20,983 Gross margin 2025: € 20,983 ▲ 143% vs 2024 (€ 8,634) Favourable step	▲ 143%
Profit after taxes	€ 25,865 Profit after taxes 2022: € 25,865 First fiscal year in the series	€ -85,618 Profit after taxes 2023: € -85,618 ▼ € 111,483 vs 2022 (€ 25,865) Unfavourable step	€ -4,050 Profit after taxes 2024: € -4,050 ▲ € 81,568 vs 2023 (€ -85,618) Favourable step	€ 11,008 Profit after taxes 2025: € 11,008 ▲ € 15,057 vs 2024 (€ -4,050) Favourable step	▲ € 15,057
Equity	€ 520,738 Equity 2022: € 520,738 First fiscal year in the series	€ 435,120 Equity 2023: € 435,120 ▼ 16% vs 2022 (€ 520,738) Unfavourable step	€ 431,070 Equity 2024: € 431,070 ▼ 1% vs 2023 (€ 435,120) Unfavourable step	€ 426,358 Equity 2025: € 426,358 ▼ 1% vs 2024 (€ 431,070) Unfavourable step	▼ 1%
Total debts	€ 120,360 Total debts 2022: € 120,360 First fiscal year in the series	€ 107,989 Total debts 2023: € 107,989 ▼ 10% vs 2022 (€ 120,360) Favourable step	€ 138,250 Total debts 2024: € 138,250 ▲ 28% vs 2023 (€ 107,989) Unfavourable step	€ 139,955 Total debts 2025: € 139,955 ▲ 1% vs 2024 (€ 138,250) Unfavourable step	▲ 1%
Cash	€ 93,327 Cash 2022: € 93,327 First fiscal year in the series	€ 34,015 Cash 2023: € 34,015 ▼ 64% vs 2022 (€ 93,327) Unfavourable step	€ 10,726 Cash 2024: € 10,726 ▼ 68% vs 2023 (€ 34,015) Unfavourable step	€ 31,074 Cash 2025: € 31,074 ▲ 190% vs 2024 (€ 10,726) Favourable step	▲ 190%
Land & buildings	€ 52,263 Land & buildings 2022: € 52,263 First fiscal year in the series	€ 49,055 Land & buildings 2023: € 49,055 ▼ 6% vs 2022 (€ 52,263) Unchanged	€ 45,847 Land & buildings 2024: € 45,847 ▼ 7% vs 2023 (€ 49,055) Unchanged	€ 42,639 Land & buildings 2025: € 42,639 ▼ 7% vs 2024 (€ 45,847) Unchanged	▼ 7%
Retained profit	€ 500,738 Retained profit 2022: € 500,738 First fiscal year in the series	€ 415,120 Retained profit 2023: € 415,120 ▼ 17% vs 2022 (€ 500,738) Unfavourable step	€ 411,070 Retained profit 2024: € 411,070 ▼ 1% vs 2023 (€ 415,120) Unfavourable step	€ 406,358 Retained profit 2025: € 406,358 ▼ 1% vs 2024 (€ 411,070) Unfavourable step	▼ 1%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 15,720 Dividend 2025: € 15,720 Unchanged (€ 0) Unchanged
Bank debt	€ 85,894 Bank debt 2022: € 85,894 First fiscal year in the series	€ 74,645 Bank debt 2023: € 74,645 ▼ 13% vs 2022 (€ 85,894) Favourable step	€ 62,752 Bank debt 2024: € 62,752 ▼ 16% vs 2023 (€ 74,645) Favourable step	€ 50,155 Bank debt 2025: € 50,155 ▼ 20% vs 2024 (€ 62,752) Favourable step	▼ 20%
Balance sheet total	€ 641,098 Balance sheet total 2022: € 641,098 First fiscal year in the series	€ 543,109 Balance sheet total 2023: € 543,109 ▼ 15% vs 2022 (€ 641,098) Unchanged	€ 569,321 Balance sheet total 2024: € 569,321 ▲ 5% vs 2023 (€ 543,109) Unchanged	€ 566,313 Balance sheet total 2025: € 566,313 ▼ 1% vs 2024 (€ 569,321) Unchanged	▼ 1%

Key figures of DEXAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DEXAMED?

What happened at DEXAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 23, 2025 New annual accounts for financial year 2025: profit of € 11,008. Source: NBB ↗
2023 Xavier Deklerck became a director. NBB
Feb 8, 2007 New establishment in Oostkamp. KBO
Jan 8, 2007 Start of the company according to the CBE. KBO

In short

From € 25,865 profit in 2022 to € 11,008 profit in 2025.

Paid € 21,761 in corporate taxes since 2022.

Best year ever: 2022, with € 25,865 profit.

Paid out € 17,320 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Xavier Deklerck

DEXAMED

Eledricity 20.6%

Surgical Sensors 10.5%

Behind DEXAMED is Xavier Deklerck. It owns 20.6% of Eledricity and 10.5% of Surgical Sensors itself.

Directors

According to the 2025 annual accounts

Xavier Deklerck

Director

Also active at: SandStone-Medical, BGP-MEDICAL

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Blauwhuisstraat 26

8020 Oostkamp

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

BGP-MEDICAL same network

€ 2,268 gross margin · 2025

Endo-Precision

€ -22,507 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0886.182.892

VAT number

BE 0886.182.892

Registered office

Blauwhuisstraat 26, 8020 Oostkamp

Names & denominations

DEXAMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 January 2007

Peppol

Active · Active since 27 Mar 2025

Activities · NACE

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en lease van medisch en paramedisch materieel

Verhuur van medisch en paramedisch materieel

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

DEXAMED

Financials

What happened to DEXAMED?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions